IMMX
Immix Biopharma
$8.13
+$0.07 (+0.93%)Oct 28, 2026
Key metrics
The numbers that frame IMMX today
- Market cap
- $581.26M
- ROIC
- -1,845.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.85
- 52wk High
- $15.10
Growth
Revenue and earnings trend for IMMX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IMMX
Is Immix Biopharma a good buy?
Hold. Immix Biopharma has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Immix Biopharma is selling at a very high price.
What is the market capitalization of IMMX?
Immix Biopharma's market capitalization is $581.26M.
What is the 52-week high for IMMX stock?
The 52-week high for Immix Biopharma is $15.10. The current close of $8.13 is 46.2% below that high.
What is the 52-week low for IMMX stock?
The 52-week low for Immix Biopharma is $2.85. The current close of $8.13 is 185% above that low.
Does IMMX stock pay dividends?
Immix Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IMMX?
Immix Biopharma's Debt / Equity ratio is 0.